Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1101 - 1200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1101 | 26815534 |
US |
51 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1102 | 26815537 |
US |
14 | 1 |
Sensitivity to weather change, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1103 | 26815573 |
US |
2 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, TESTOSTERONE CYPIONATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 1104 | 26815574 |
US |
29 | 1 |
Skin lesion, Therapeutic response shortened, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1105 | 26815603 |
US |
24 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1106 | 26815934 |
GB |
6 | 2 |
Croup infectious, Dyspnoea, Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1107 | 26815935 |
US |
2 | |
Discomfort, Sleep disorder due to a general medical condition, Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1108 | 26816292 |
US |
48 | 2 |
Dermatitis atopic, Drug effect less than expected, |
||||
DUPILUMAB, |
||||
| 1109 | 26816296 |
US |
51 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1110 | 26817106 |
US |
47 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1111 | 26817112 |
US |
54 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1112 | 26817120 |
US |
2 | |
Dermatitis atopic, Rash, Discomfort, Drug ineffective, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1113 | 26817306 |
US |
17 | 2 |
Dermatitis atopic, Rash, Skin discomfort, |
||||
DUPILUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 1114 | 26817311 |
US |
41 | 1 |
Dermatitis atopic, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1115 | 26808954 |
US |
71 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1116 | 26809079 |
US |
32 | 2 |
Impaired quality of life, Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 1117 | 26809091 |
US |
44 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1118 | 26809103 |
US |
25 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1119 | 26809235 |
US |
2 | |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1120 | 26809254 |
US |
16 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1121 | 26809449 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1122 | 26809466 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1123 | 26809651 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE, MAGNESIUM, MONTELUKAST SODIUM, |
||||
| 1124 | 26809676 |
US |
28 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1125 | 26809861 |
US |
50 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1126 | 26809865 |
US |
3 | 1 |
Dermatitis atopic, Skin fissures, |
||||
DUPILUMAB, |
||||
| 1127 | 26809890 |
US |
19 | 2 |
Dermatitis atopic, Skin exfoliation, Erythema, Pruritus, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 1128 | 26810084 |
US |
2 | |
Urinary tract infection, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUOCINOLONE ACETONIDE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, BUPROPION HYDROCHLORIDE, |
||||
| 1129 | 26810116 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1130 | 26810388 |
US |
66 | 2 |
Dry mouth, Dry skin, Dermatitis atopic, Dry eye, Injection site pain, Product preparation issue, |
||||
DUPILUMAB, |
||||
| 1131 | 26810590 |
US |
1 | |
Dry skin, Dermatitis atopic, Skin fissures, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 1132 | 26810721 |
US |
57 | 2 |
Surgery, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, EZETIMIBE, DAPAGLIFLOZIN, FENOFIBRATE, GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), LOSARTAN POTASSIUM, LOSARTAN, DEXLANSOPRAZOLE, |
||||
| 1133 | 26810744 |
US |
39 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1134 | 26810840 |
US |
23 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1135 | 26810850 |
US |
4 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1136 | 26810861 |
US |
61 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1137 | 26810885 |
US |
54 | 1 |
Gingival swelling, Swollen tongue, Toothache, Tooth fracture, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1138 | 26810895 |
US |
3 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1139 | 26810911 |
US |
5 | 2 |
Dermatitis atopic, Pruritus, Therapeutic response shortened, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1140 | 26811135 |
US |
24 | 2 |
Dermatitis atopic, Scar, Dry skin, Skin fissures, Erythema, Skin swelling, Skin texture abnormal, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1141 | 26811438 |
GB |
87 | 1 |
Sepsis, Psoriasis, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1142 | 26811441 |
US |
4 | 2 |
Dermatitis atopic, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1143 | 26811449 |
US |
15 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1144 | 26811453 |
US |
26 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1145 | 26811466 |
US |
2 | |
Rash macular, Dermatitis contact, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1146 | 26811685 |
US |
1 | |
Rash, Dermatitis atopic, Pruritus, Skin burning sensation, Erythema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1147 | 26811771 |
US |
35 | 1 |
Dermatitis atopic, Sleep disorder, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1148 | 26812525 |
US |
64 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1149 | 26812527 |
US |
82 | 2 |
Fall, Illness, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1150 | 26812807 |
US |
55 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1151 | 26812878 |
EU |
31 | 2 |
Arthralgia, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
| 1152 | 26812887 |
US |
68 | 2 |
Pruritus, Rash erythematous, Dermatitis atopic, Accidental exposure to product, Exposure via skin contact, Injection site erythema, Injection site pain, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, UPADACITINIB, |
||||
| 1153 | 26812963 |
US |
34 | 1 |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUOXETINE HYDROCHLORIDE, TAPINAROF, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 1154 | 26816395 |
49 | 1 | |
Dermatitis atopic, Swelling, Pruritus, Erythema, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1155 | 26804141 |
US |
56 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LOSARTAN POTASSIUM, LOSARTAN, DIVALPROEX SODIUM, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 1156 | 26804247 |
US |
30 | 2 |
Dermatitis atopic, |
||||
LUMATEPERONE, DUPILUMAB, DUPILUMAB, DUPILUMAB, HYDROCORTISONE, QUETIAPINE, QUETIAPINE, LAMOTRIGINE, |
||||
| 1157 | 26804481 |
US |
6 | 1 |
Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1158 | 26804725 |
US |
44 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1159 | 26804744 |
US |
32 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, UPADACITINIB, |
||||
| 1160 | 26805022 |
US |
45 | 2 |
Dermatitis atopic, Skin fissures, Skin ulcer, |
||||
DUPILUMAB, |
||||
| 1161 | 26805085 |
US |
79 | |
Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1162 | 26805160 |
US |
1 | |
Dermatitis atopic, Product use in unapproved indication, |
||||
OMALIZUMAB, |
||||
| 1163 | 26805230 |
US |
21 | 2 |
Anaphylactic reaction, Throat tightness, Off label use, Urticaria, Dizziness, Dermatitis atopic, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, EPINEPHRINE, BUPROPION, IVABRADINE, FEXOFENADINE, MAGNESIUM, HYDROXYZINE, |
||||
| 1164 | 26805282 |
US |
30 | 1 |
Dry skin, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1165 | 26805288 |
US |
43 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1166 | 26805291 |
US |
23 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1167 | 26805393 |
US |
68 | 2 |
Dermatitis atopic, Device delivery system issue, Pruritus, Injection site urticaria, Injection site pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1168 | 26805423 |
US |
||
Dermatitis atopic, Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1169 | 26805526 |
US |
47 | |
Dermatitis atopic, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1170 | 26805617 |
US |
21 | 2 |
Dermatitis atopic, Rash, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1171 | 26805626 |
US |
75 | 2 |
Dermatitis atopic, Knee arthroplasty, |
||||
DUPILUMAB, |
||||
| 1172 | 26805632 |
US |
39 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1173 | 26805645 |
US |
17 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1174 | 26805664 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1175 | 26805871 |
US |
32 | 2 |
Dermatitis atopic, Injection site reaction, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1176 | 26806129 |
US |
2 | |
Injection site infection, Injection site swelling, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1177 | 26806136 |
US |
52 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1178 | 26806148 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1179 | 26806149 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1180 | 26806547 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1181 | 26806556 |
US |
44 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1182 | 26806558 |
US |
54 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Skin exfoliation, Skin fissures, |
||||
DUPILUMAB, |
||||
| 1183 | 26806559 |
US |
19 | 2 |
Dermatitis atopic, Blepharitis, Erythema of eyelid, Swelling of eyelid, Eyelids pruritus, Eye inflammation, |
||||
DUPILUMAB, |
||||
| 1184 | 26806565 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1185 | 26806692 |
US |
28 | |
Dermatitis atopic, Dry skin, Temperature intolerance, Skin discharge, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1186 | 26806916 |
US |
52 | |
Seborrhoea, Acne, Pruritus, Rash, Dermatitis atopic, Skin discomfort, Sleep disorder, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1187 | 26806954 |
US |
60 | 1 |
Dermatitis atopic, Skin fissures, Skin burning sensation, Intentional dose omission, Rebound effect, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1188 | 26806955 |
US |
76 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1189 | 26806963 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1190 | 26807277 |
US |
64 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1191 | 26807605 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1192 | 26807919 |
US |
70 | 2 |
Fatigue, Dermatitis atopic, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1193 | 26807950 |
US |
29 | 1 |
Dermatitis atopic, Therapeutic product effect decreased, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1194 | 26808134 |
US |
41 | 2 |
Fatigue, Dermatitis atopic, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1195 | 26808166 |
US |
50 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 1196 | 26808172 |
US |
23 | |
Dermatitis atopic, Erythema, Skin warm, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1197 | 26808303 |
US |
18 | |
Dermatitis atopic, Scab, Discomfort, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1198 | 26808398 |
US |
20 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1199 | 26808685 |
US |
17 | 2 |
Dermatitis atopic, Fall, Patella fracture, |
||||
DUPILUMAB, |
||||
| 1200 | 26798359 |
US |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30